These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drugs in resuscitation: an update. Lee SW Singapore Med J; 2011 Aug; 52(8):596-602. PubMed ID: 21879219 [TBL] [Abstract][Full Text] [Related]
5. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation: physiologic and educational rationale for changes. White RD Mayo Clin Proc; 2006 Jun; 81(6):736-40. PubMed ID: 16770973 [No Abstract] [Full Text] [Related]
6. Medications in adult cardiac arrest. ARC and NZRC Guideline 2010. ; Emerg Med Australas; 2011 Jun; 23(3):282-5. PubMed ID: 21668711 [No Abstract] [Full Text] [Related]
7. Vasopressor agents for cardiopulmonary resuscitation. Cao L; Weil MH; Sun S; Tang W J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):115-21. PubMed ID: 12808484 [TBL] [Abstract][Full Text] [Related]
8. Thrombolysis and other drugs during cardiopulmonary resuscitation. Spöhr F; Wenzel V; Böttiger BW Curr Opin Crit Care; 2008 Jun; 14(3):292-8. PubMed ID: 18467889 [TBL] [Abstract][Full Text] [Related]
9. Update on advanced life support and resuscitation techniques. Hong MF; Dorian P Curr Opin Cardiol; 2005 Jan; 20(1):1-6. PubMed ID: 15596952 [TBL] [Abstract][Full Text] [Related]
14. Sodium nitroprusside-enhanced cardiopulmonary resuscitation improves resuscitation rates after prolonged untreated cardiac arrest in two porcine models. Schultz JC; Segal N; Caldwell E; Kolbeck J; McKnite S; Lebedoff N; Zviman M; Aufderheide TP; Yannopoulos D Crit Care Med; 2011 Dec; 39(12):2705-10. PubMed ID: 21725236 [TBL] [Abstract][Full Text] [Related]
15. Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest. Bartos JA; Matsuura TR; Sarraf M; Youngquist ST; McKnite SH; Rees JN; Sloper DT; Bates FS; Segal N; Debaty G; Lurie KG; Neumar RW; Metzger JM; Riess ML; Yannopoulos D Resuscitation; 2015 Feb; 87():7-13. PubMed ID: 25447036 [TBL] [Abstract][Full Text] [Related]
16. Overview of American Heart Association protocols. Part 2--A.C.L.S. Ryan WA Tex Dent J; 2000 Jun; 117(6):80-6. PubMed ID: 11857856 [No Abstract] [Full Text] [Related]
17. Pharmacotherapy for a pulseless cardiac arrest. Hays AJ; Corso Y AACN Adv Crit Care; 2007; 18(4):337-43; quiz 404-5. PubMed ID: 17978605 [No Abstract] [Full Text] [Related]
18. Variable effects of high-dose adrenaline relative to standard-dose adrenaline on resuscitation outcomes according to cardiac arrest duration. Jeung KW; Ryu HH; Song KH; Lee BK; Lee HY; Heo T; Min YI Resuscitation; 2011 Jul; 82(7):932-6. PubMed ID: 21482013 [TBL] [Abstract][Full Text] [Related]
19. Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. de Oliveira FC; Feitosa-Filho GS; Ritt LE Resuscitation; 2012 Jun; 83(6):674-83. PubMed ID: 22306254 [TBL] [Abstract][Full Text] [Related]
20. The role of Levosimendan in cardiopulmonary resuscitation. Varvarousi G; Stefaniotou A; Varvaroussis D; Aroni F; Xanthos T Eur J Pharmacol; 2014 Oct; 740():596-602. PubMed ID: 24972240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]